Insider Transactions Reported by 12 Insiders of BioAge Labs, Inc.

Symbol
BIOA on Nasdaq
Location
Emeryville, CA

Insiders trading volume in the past year

BioAge Labs, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vijay Satyanand Pande Director $58,197,060 07 Aug 2025
JAMES HEALY Director $41,488,218 05 Jun 2025
PATRICK G. ENRIGHT Director $30,790,602 05 Jun 2025
Cormorant Asset Management, LP Former 10% Owner $29,331,522 27 Sep 2024
Kristen Fortney Chief Executive Officer, Director $17,698,701 -$4,223,036 -19% 13 Jan 2026
Eric Morgen Chief Operating Officer, Director $1,210,050 18 Feb 2025
Dov A. Goldstein Chief Financial Officer $113,661 -$531,828 -82% 16 Jan 2026
Rekha Hemrajani Director $54,000 05 Jun 2025
Shane Barton Principal Accounting Officer $47,376 18 Feb 2025
PAUL D. RUBIN Chief Medical Officer $0 -$1,013,399 -100% 02 Jan 2026
Michael H. Davidson Director 05 Jun 2025
JEAN PIERRE GARNIER Director 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for BioAge Labs, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.